Product
GTX-104
2 clinical trials
2 indications
Indication
Subarachnoid Hemorrhage (Aneurysmal)Clinical trial
Safety and Tolerability of GTX-104 (Nimodipine Injection for IV Infusion) Compared With Oral Nimodipine in Patients Hospitalized for Aneurysmal Subarachnoid Hemorrhage (aSAH): a Prospective, Randomized TrialStatus: Recruiting, Estimated PCD: 2024-11-01
Clinical trial
A Phase 1, Randomized, Two-Period Crossover Study to Evaluate the Relative Bioavailability of Intravenous GTX-104 Compared to Oral Nimodipine Capsules at Steady State in Healthy Male and Female SubjectsStatus: Completed, Estimated PCD: 2022-02-17